COVID-19

Updated September 11, 2020 2:23 p.m.

Wearing masks to limit the spread of COVID-19

The best protection against coronavirus is good handwashing.

Returning to Research Guidance and Updates

Emory Research Guidance During COVID-19

Guidance for Faculty Regarding Student Involvement in Research During COVID-19

Other Pertinent Emory University Updates

Health Information/Protecting Yourself in the Workplace

Important point on medications from Governor Kemp's briefing on March 23, 2020, signs Executive Order

All licensed Georgia pharmacists are now permitted to dispense a ninety-day supply of a prescription drug if a patient has no remaining refills and the pharmacist cannot get in contact with the prescribing provider. Pharmacists may also dispense early refills for prescription drugs. However, these authorizations do not apply to Schedule II controlled substances.


Emory University

Centers for Disease Control and Prevention

Journal of the American Medical Association

National Institute of Environmental Health Sciences

World Health Organization
 
Other Resources

 

Upcoming Webinars

Please check back for updates.

Previously Recorded Webinars

Fridays at Four - Research Webinars

This virtual meeting is an ongoing series of research webinars to help faculty understand the University's and sponsor's research guidance and maintain research continuity in the time of COVID-19.

 


Nell Hodgson Woodruff School of Nursing

Office for Clinical Research

Office of the Senior Vice President for Research

Rollins School of Public Health


Georgia Clinical & Translational Science Alliance

National Council of University Research Administrators

National Institutes of Health

Emory COVID-19 Research News

Sponsored Research COVID-19 Guidance

The Office of Research Administration has been compiling as much information as possible on impacts to sponsored research from COVID-19. ORA will continue to update this page with information as we receive it from each agency. In addition, we have compiled a list of Frequently Asked Questions related to sponsored research. As we receive more questions, and answers, we will continue to update the list.

 

Agency for Healthcare Research and Quality (AHRQ)

American Cancer Society

American Heart Association

Resource from AHA:

Centers for Disease Control and Prevention

Resources from the CDC include:

Council on Governmental Relations

Department of Defense

Hanover Research

Health Resources & Services Administration (HRSA)

National Cancer Institute

National Institutes of Health

NIH Website: Coronavirus Disease 2019 (COVID-19)
Resources from NIH include:

National Science Foundation

The National Science Foundation has developed a new website for the research community with their detailed guidance on COVID-19, including Frequently Asked Questions. Of interest, NSF has confirmed that they will continue to accept proposal submissions and adhere to currently stated deadlines.

 


Sponsor-specific Information from Additional Sponsors

COVID-19 Research Opportunities

Ex Libris Pivot & Research Professional

Georgia CTSA Weekly eRoundup

GrantForward

LifeArc

National Center for Advancing Translational Sciences

National Institute for Health Research

National Institute of Allergy and Infectious Diseases

National Institute of Biomedical Imaging and Bioengineering

National Institute of General Medical Sciences

National Institute on Drug Abuse

National Institutes of Health

National Institute on Aging

National Institute of Mental Health

National Institute on Minority Health and Health Disparities

National Science Foundation

Office of Behavioral and Social Sciences Research

Patient-Centered Outcomes Research Institute

System for Award Management

University of Texas at Austin

COVID-19 Research Resources

Amazon Web Services for Coronavirus Research

Emory’s Amazon Web Services (AWS) partners informed LITS that the AWS Disaster Response Program is coordinating across AWS to identify organizations, customers, and partners active in gene sequencing, diagnostics, epidemic modeling, vaccine development, treatment development, and monitoring & evaluation for Novel Coronavirus (nCoV) for immediate and long-term engagement.

In many cases, they will provide promotional AWS utilization credits for Cloud-based research toward the Coronavirus and they are available to help submit cases for credits.  LITS is available to help researchers onboard and navigate AWS in the Emory Cloud computing environment.

If anyone is interested, please contact LITS at aws.help@emory.edu .

Digital Science Dimensions

Dimensions is updated once every 24 hours, so the latest research can be viewed alongside existing information. With its range of research outputs including datasets and clinical trials, both of which are just as important as journal articles in the face of a potential pandemic, Dimensions is a one-stop shop for all COVID-19 related information.  Please click here for more information.

Extreme Science and Engineering Discovery Environment

XSEDE’s HPC-COVID19 Consortium, charged with meeting the high-performance computing needs of COVID19-related data analytics, simulation, bioinformatics, drug design and repurposing, and other applications.

Nature Research Microbiology Community

A weekly review of the latest SARS-CoV-2 and COVID-19 literature.  Please click here for more information.

ORA Staff Information

Emory University - Human Resources

National Educational Services

Security Awareness

Quick Guide

 

Important point on medications from Governor Kemp's briefing on March 23, 2020, signs Executive Order

All licensed Georgia pharmacists are now permitted to dispense a ninety-day supply of a prescription drug if a patient has no remaining refills and the pharmacist cannot get in contact with the prescribing provider. Pharmacists may also dispense early refills for prescription drugs. However, these authorizations do not apply to Schedule II controlled substances.

 

Coronavirus Business Continuity Policy

As it pertains to the Business Continuity Policy, please refer to the email sent by Dr. Robert Nobles on March 19th. 

The Upside